menu

Optimizing Patient Outcomes in Acromegaly

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Optimizing Patient Outcomes in Acromegaly

close
0.50 credits
30 minutes
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.50 credits
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Acromegaly is a rare disorder caused by excess growth hormone production and is associated with increased morbidity and mortality. Delays in the diagnosis and initiation of therapy or the provision of suboptimal therapy often negatively impact the quality of life of these patients. Join us for this expert interview with Dr. Susan Samson and Dr. Kevin Yuen who offer insights to help you overcome the complex medical challenges often faced when managing patients with acromegaly, including strategies to apply the latest guidelines and the 2020 consensus statement into clinical practice. 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Susan L Samson, MD, PhD, FRCPC, FACE
    Senior Associate Consultant
    Mayo Clinic
    Jacksonville, FL 

    Contracted Research: Chiasma, Corcept
    Consulting Fees: Chiasma, Corcept, Novartis 

    Faculty:
    Kevin C.J. Yuen, MD
    Medical Director
    Barrow Neurological Institute
    Professor of Medicine
    University of Arizona College of Medicine; and
    Creighton School of Medicine
    Phoenix, AZ

    Contracted Research: Chiasma, Corcept, Ionis, Millendo, Novartis
    Consulting Fees: Chiasma, Corcept, Crinetics, Ipsen, Recordati Rare Diseases, Strongbridge

    Reviewers/Content Planners/Authors:

    • Elizabeth Lurwick has nothing to disclose.
    • Anna Trentini has nothing to disclose.
    • Stephen Chavez has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the signs and symptoms of acromegaly and the effect that prompt diagnosis and treatment or referral can have on quality of life
    • Recognize persistent disease after surgery, predictors of treatment failure, and current pharmacologic treatment options for acromegaly
    • Apply algorithms from the most recent guidelines and the 2020 consensus statement in clinical practice to select therapy for patients with acromegaly
  • Target Audience

    This activity is designed to meet the educational needs of endocrinologists, pituitary neurologists, primary care physicians, internal medicine specialists, and other healthcare professionals who diagnose and treat acromegaly.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

  • Commercial Support

    This activity is supported by an independent educational grant from Recordati Rare Diseases Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Acromegaly is a rare disorder caused by excess growth hormone production and is associated with increased morbidity and mortality. Delays in the diagnosis and initiation of therapy or the provision of suboptimal therapy often negatively impact the quality of life of these patients. Join us for this expert interview with Dr. Susan Samson and Dr. Kevin Yuen who offer insights to help you overcome the complex medical challenges often faced when managing patients with acromegaly, including strategies to apply the latest guidelines and the 2020 consensus statement into clinical practice. 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Susan L Samson, MD, PhD, FRCPC, FACE
    Senior Associate Consultant
    Mayo Clinic
    Jacksonville, FL 

    Contracted Research: Chiasma, Corcept
    Consulting Fees: Chiasma, Corcept, Novartis 

    Faculty:
    Kevin C.J. Yuen, MD
    Medical Director
    Barrow Neurological Institute
    Professor of Medicine
    University of Arizona College of Medicine; and
    Creighton School of Medicine
    Phoenix, AZ

    Contracted Research: Chiasma, Corcept, Ionis, Millendo, Novartis
    Consulting Fees: Chiasma, Corcept, Crinetics, Ipsen, Recordati Rare Diseases, Strongbridge

    Reviewers/Content Planners/Authors:

    • Elizabeth Lurwick has nothing to disclose.
    • Anna Trentini has nothing to disclose.
    • Stephen Chavez has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the signs and symptoms of acromegaly and the effect that prompt diagnosis and treatment or referral can have on quality of life
    • Recognize persistent disease after surgery, predictors of treatment failure, and current pharmacologic treatment options for acromegaly
    • Apply algorithms from the most recent guidelines and the 2020 consensus statement in clinical practice to select therapy for patients with acromegaly
  • Target Audience

    This activity is designed to meet the educational needs of endocrinologists, pituitary neurologists, primary care physicians, internal medicine specialists, and other healthcare professionals who diagnose and treat acromegaly.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

  • Commercial Support

    This activity is supported by an independent educational grant from Recordati Rare Diseases Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule22 Oct 2021
Webpack App